Showing 861-870 of 5771 results for "".
Long-Awaited Treatment for Demodex Blepharitis Receives FDA Approval
https://modernod.com/topics/ocular-surface/long-awaited-treatment-for-emdemodexem-blepharitis-receives-fda-approval/38645/The twice-daily prescription drop will be available by end of August 2023.New Drugs for Dry Eye and Demodex Blepharitis
https://modernod.com/topics/ocular-surface/new-drugs-for-dry-eye-and-idemodexi-blepharitis/38625/More options, more personalized treatment for patients. Get familiar with what may end up in your toolbox.What’s New and What’s Coming in OSD Treatment
https://modernod.com/topics/ocular-surface/whats-new-and-whats-coming-in-osd-treatment/38578/An overview of recent FDA approvals and potential new therapies.Modern Contact Lens Ordering
https://modernod.com/topics/contact-lenses/modern-contact-lens-ordering/38494/There’s more competition than ever from online retailers, but we can learn from them to better meet our patients where they are.Drops, Drops, Drops!
https://modernod.com/topics/ocular-surface/drops-drops-drops/38492/New pharmaceutical agents allow clinicians to rethink the way patients are treated.The Latest Roundup of Key Presbyopia–Correcting Drops
https://modernod.com/topics/technology/the-latest-roundup-of-key-presbyopia-correcting-drops/38364/Watch out for updates on drops in development.Matching Dry Eye Treatments to Patient Type
https://modernod.com/topics/ocular-surface/matching-dry-eye-treatments-to-patient-type/38261/This author divides patients into three types and treats accordingly.Answering the Call of Presbyopic Patients
https://modernod.com/topics/technology/answering-the-call-of-presbyopic-patients/38187/The number of patients with this age-related condition is on the rise; are you prepared to meet their needs?Innovations in Dry Eye Treatment
https://modernod.com/topics/ocular-surface/innovations-in-dry-eye-treatment-1/38119/What’s coming and what’s on the horizon.What’s on Your Radar?
https://modernod.com/topics/glaucoma/whats-on-your-radar/37907/A rundown of some promising ophthalmic therapeutics coming down the pike.